Concepts (195)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Impulsive Behavior | 2 | 2017 | 78 | 1.24 | Why? |
| Attention | 2 | 2017 | 335 | 1.01 | Why? |
| Attention Deficit Disorder with Hyperactivity | 2 | 2017 | 441 | 0.81 | Why? |
| Homeless Persons | 4 | 2020 | 1171 | 0.79 | Why? |
| Prescription Drug Monitoring Programs | 1 | 2018 | 20 | 0.77 | Why? |
| Deinstitutionalization | 1 | 2018 | 17 | 0.74 | Why? |
| Thiadiazoles | 1 | 2017 | 15 | 0.68 | Why? |
| Quinuclidines | 1 | 2017 | 22 | 0.68 | Why? |
| Developed Countries | 2 | 2018 | 500 | 0.65 | Why? |
| Influenza Vaccines | 3 | 2018 | 2941 | 0.64 | Why? |
| alpha7 Nicotinic Acetylcholine Receptor | 1 | 2017 | 92 | 0.63 | Why? |
| Attitude to Health | 3 | 2020 | 2002 | 0.57 | Why? |
| Influenza, Human | 7 | 2020 | 10779 | 0.56 | Why? |
| Extensively Drug-Resistant Tuberculosis | 1 | 2014 | 87 | 0.54 | Why? |
| Tuberculosis | 3 | 2018 | 2895 | 0.50 | Why? |
| Sex Workers | 1 | 2017 | 348 | 0.50 | Why? |
| Drug Prescriptions | 2 | 2018 | 1062 | 0.49 | Why? |
| Pneumococcal Vaccines | 1 | 2018 | 571 | 0.47 | Why? |
| Pneumococcal Infections | 1 | 2018 | 562 | 0.45 | Why? |
| Spatial Analysis | 1 | 2017 | 878 | 0.44 | Why? |
| Health Services | 1 | 2017 | 765 | 0.42 | Why? |
| Patient Acceptance of Health Care | 2 | 2021 | 5002 | 0.41 | Why? |
| Medicine | 1 | 2017 | 485 | 0.41 | Why? |
| England | 9 | 2021 | 5116 | 0.39 | Why? |
| Infectious Disease Transmission, Professional-to-Patient | 1 | 2017 | 1316 | 0.38 | Why? |
| Prisoners | 1 | 2017 | 738 | 0.37 | Why? |
| Medication Adherence | 1 | 2018 | 1270 | 0.35 | Why? |
| Guideline Adherence | 1 | 2021 | 2309 | 0.35 | Why? |
| Anti-Infective Agents | 1 | 2018 | 1766 | 0.32 | Why? |
| Social Marginalization | 2 | 2017 | 115 | 0.32 | Why? |
| Substance-Related Disorders | 2 | 2017 | 2038 | 0.30 | Why? |
| Ambulatory Care Facilities | 1 | 2017 | 2063 | 0.29 | Why? |
| Primary Health Care | 3 | 2018 | 4839 | 0.29 | Why? |
| Transients and Migrants | 1 | 2017 | 1468 | 0.29 | Why? |
| Tuberculosis, Pulmonary | 1 | 2014 | 1171 | 0.27 | Why? |
| Communicable Diseases, Emerging | 2 | 2017 | 2523 | 0.26 | Why? |
| Practice Patterns, Physicians' | 2 | 2018 | 4927 | 0.24 | Why? |
| Liver Diseases | 1 | 2018 | 2698 | 0.23 | Why? |
| Vaccination | 2 | 2017 | 19050 | 0.22 | Why? |
| London | 5 | 2020 | 2166 | 0.21 | Why? |
| Wales | 2 | 2021 | 758 | 0.21 | Why? |
| Homeless Youth | 1 | 2020 | 29 | 0.21 | Why? |
| Markov Chains | 1 | 2020 | 502 | 0.18 | Why? |
| Rats, Transgenic | 1 | 2017 | 10 | 0.18 | Why? |
| Klebsiella | 1 | 2017 | 35 | 0.17 | Why? |
| Drug Resistance, Bacterial | 2 | 2018 | 1414 | 0.17 | Why? |
| Photic Stimulation | 1 | 2017 | 74 | 0.17 | Why? |
| Furunculosis | 1 | 2015 | 1 | 0.16 | Why? |
| Isoniazid | 1 | 2017 | 105 | 0.16 | Why? |
| Hemagglutinins | 1 | 2017 | 143 | 0.15 | Why? |
| Public Health | 1 | 2021 | 16359 | 0.14 | Why? |
| Health Services Accessibility | 3 | 2020 | 10697 | 0.14 | Why? |
| Housing | 2 | 2020 | 1146 | 0.14 | Why? |
| Urinary Tract Infections | 2 | 2017 | 534 | 0.14 | Why? |
| Community Participation | 1 | 2021 | 605 | 0.13 | Why? |
| Latent Tuberculosis | 1 | 2018 | 324 | 0.13 | Why? |
| Analysis of Variance | 1 | 2017 | 950 | 0.13 | Why? |
| Escherichia coli Infections | 1 | 2017 | 348 | 0.13 | Why? |
| Choice Behavior | 1 | 2017 | 319 | 0.13 | Why? |
| Abscess | 1 | 2015 | 234 | 0.12 | Why? |
| Influenza A Virus, H1N1 Subtype | 2 | 2020 | 2984 | 0.12 | Why? |
| Hemagglutinin Glycoproteins, Influenza Virus | 1 | 2017 | 511 | 0.12 | Why? |
| Streptococcus pneumoniae | 1 | 2018 | 827 | 0.12 | Why? |
| Health Status Disparities | 3 | 2020 | 4072 | 0.12 | Why? |
| Influenza A Virus, H3N2 Subtype | 1 | 2017 | 572 | 0.12 | Why? |
| Mortality | 2 | 2020 | 7132 | 0.12 | Why? |
| Skilled Nursing Facilities | 1 | 2021 | 1098 | 0.12 | Why? |
| Klebsiella Infections | 1 | 2017 | 466 | 0.11 | Why? |
| Residential Facilities | 1 | 2017 | 443 | 0.11 | Why? |
| Tuberculosis, Multidrug-Resistant | 1 | 2017 | 433 | 0.11 | Why? |
| Humans | 33 | 2021 | 930598 | 0.11 | Why? |
| Long-Term Care | 3 | 2021 | 2047 | 0.11 | Why? |
| Morbidity | 1 | 2017 | 1426 | 0.11 | Why? |
| Prisons | 1 | 2020 | 980 | 0.11 | Why? |
| Health Personnel | 2 | 2020 | 29646 | 0.10 | Why? |
| Antitubercular Agents | 1 | 2017 | 775 | 0.10 | Why? |
| Seroconversion | 1 | 2020 | 2515 | 0.10 | Why? |
| Influenza A Virus, H7N9 Subtype | 1 | 2014 | 415 | 0.10 | Why? |
| Hepatitis B | 1 | 2018 | 888 | 0.10 | Why? |
| Health Services for the Aged | 1 | 2017 | 602 | 0.10 | Why? |
| Escherichia coli | 1 | 2017 | 1547 | 0.10 | Why? |
| Rats | 1 | 2017 | 2764 | 0.09 | Why? |
| United Kingdom | 5 | 2021 | 18046 | 0.09 | Why? |
| Infant | 4 | 2020 | 30274 | 0.09 | Why? |
| Disease Models, Animal | 2 | 2017 | 10998 | 0.09 | Why? |
| Infant, Newborn | 3 | 2018 | 23105 | 0.09 | Why? |
| Electronic Health Records | 2 | 2020 | 3492 | 0.09 | Why? |
| Mycobacterium tuberculosis | 1 | 2017 | 1164 | 0.09 | Why? |
| State Medicine | 1 | 2021 | 2847 | 0.08 | Why? |
| Dose-Response Relationship, Drug | 1 | 2017 | 3776 | 0.08 | Why? |
| Nursing Homes | 2 | 2021 | 4155 | 0.08 | Why? |
| Cross Infection | 2 | 2020 | 8675 | 0.08 | Why? |
| Child, Preschool | 4 | 2020 | 36283 | 0.08 | Why? |
| Delivery of Health Care, Integrated | 1 | 2018 | 1549 | 0.08 | Why? |
| Influenza A virus | 1 | 2018 | 2234 | 0.08 | Why? |
| Hepatitis C | 1 | 2018 | 1514 | 0.08 | Why? |
| Atrial Fibrillation | 1 | 2020 | 2320 | 0.08 | Why? |
| Incidence | 4 | 2021 | 25622 | 0.08 | Why? |
| Adult | 12 | 2020 | 244371 | 0.07 | Why? |
| Immunogenicity, Vaccine | 1 | 2021 | 4624 | 0.07 | Why? |
| Risk Factors | 6 | 2021 | 71621 | 0.07 | Why? |
| Vulnerable Populations | 1 | 2020 | 3099 | 0.07 | Why? |
| Schizophrenia | 1 | 2015 | 1018 | 0.07 | Why? |
| Socioeconomic Factors | 3 | 2017 | 8495 | 0.07 | Why? |
| Brain Ischemia | 1 | 2020 | 2813 | 0.07 | Why? |
| Male | 14 | 2021 | 367725 | 0.07 | Why? |
| Child | 4 | 2018 | 70012 | 0.07 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.07 | Why? |
| Female | 14 | 2021 | 380317 | 0.07 | Why? |
| Aged | 10 | 2021 | 215776 | 0.06 | Why? |
| Algorithms | 1 | 2020 | 7346 | 0.06 | Why? |
| Parents | 1 | 2017 | 2758 | 0.06 | Why? |
| Chronic Disease | 1 | 2018 | 5139 | 0.06 | Why? |
| HIV-1 | 1 | 2018 | 3365 | 0.06 | Why? |
| Cohort Studies | 4 | 2021 | 36005 | 0.06 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.06 | Why? |
| Middle Aged | 10 | 2021 | 270681 | 0.06 | Why? |
| Risk Assessment | 3 | 2020 | 25439 | 0.06 | Why? |
| Smoking | 1 | 2015 | 3358 | 0.06 | Why? |
| Prospective Studies | 3 | 2021 | 43301 | 0.06 | Why? |
| Adolescent | 5 | 2018 | 86841 | 0.06 | Why? |
| Research Design | 1 | 2018 | 5830 | 0.05 | Why? |
| Young Adult | 5 | 2018 | 93724 | 0.05 | Why? |
| Coronavirus Infections | 6 | 2020 | 253789 | 0.05 | Why? |
| Age Factors | 2 | 2021 | 21039 | 0.05 | Why? |
| Electronics | 1 | 2021 | 199 | 0.05 | Why? |
| Biomedical Research | 1 | 2020 | 5270 | 0.05 | Why? |
| Hospitalization | 2 | 2020 | 54280 | 0.05 | Why? |
| Watchful Waiting | 1 | 2021 | 276 | 0.05 | Why? |
| Angiotensins | 1 | 2020 | 259 | 0.05 | Why? |
| Follow-Up Studies | 1 | 2017 | 17020 | 0.05 | Why? |
| Community-Based Participatory Research | 1 | 2021 | 271 | 0.05 | Why? |
| Travel | 1 | 2017 | 7220 | 0.04 | Why? |
| Antibodies, Viral | 2 | 2021 | 51949 | 0.04 | Why? |
| Prognosis | 2 | 2020 | 32490 | 0.04 | Why? |
| Pandemics | 8 | 2021 | 389249 | 0.04 | Why? |
| Contraindications | 1 | 2017 | 96 | 0.04 | Why? |
| Genetic Drift | 1 | 2017 | 54 | 0.04 | Why? |
| Stroke | 1 | 2020 | 8839 | 0.04 | Why? |
| Polymorphism, Restriction Fragment Length | 1 | 2017 | 116 | 0.04 | Why? |
| Animals | 2 | 2017 | 78931 | 0.04 | Why? |
| Epidemics | 1 | 2017 | 6407 | 0.04 | Why? |
| Genome, Viral | 1 | 2018 | 13157 | 0.04 | Why? |
| Cardiovascular Diseases | 1 | 2020 | 11497 | 0.04 | Why? |
| Anti-Bacterial Agents | 1 | 2017 | 10083 | 0.04 | Why? |
| Pneumonia, Viral | 5 | 2020 | 243684 | 0.04 | Why? |
| Pregnancy | 1 | 2017 | 23879 | 0.03 | Why? |
| Obesity | 1 | 2015 | 7388 | 0.03 | Why? |
| Urine | 1 | 2017 | 469 | 0.03 | Why? |
| Containment of Biohazards | 1 | 2020 | 762 | 0.03 | Why? |
| Immunization Schedule | 1 | 2021 | 1305 | 0.03 | Why? |
| Inappropriate Prescribing | 1 | 2017 | 284 | 0.03 | Why? |
| Databases, Factual | 2 | 2020 | 6248 | 0.03 | Why? |
| Surveys and Questionnaires | 2 | 2017 | 43792 | 0.03 | Why? |
| Middle East Respiratory Syndrome Coronavirus | 1 | 2014 | 8843 | 0.03 | Why? |
| Molecular Epidemiology | 1 | 2018 | 1638 | 0.03 | Why? |
| Glycosylation | 1 | 2017 | 1255 | 0.03 | Why? |
| Women's Health | 1 | 2017 | 444 | 0.03 | Why? |
| Disease Outbreaks | 2 | 2018 | 27595 | 0.03 | Why? |
| HIV Infections | 1 | 2018 | 11620 | 0.03 | Why? |
| Preventive Health Services | 1 | 2017 | 501 | 0.03 | Why? |
| Molecular Sequence Data | 1 | 2017 | 3198 | 0.03 | Why? |
| Klebsiella pneumoniae | 1 | 2017 | 658 | 0.03 | Why? |
| Recombination, Genetic | 1 | 2018 | 1265 | 0.03 | Why? |
| Global Health | 1 | 2014 | 13911 | 0.03 | Why? |
| Mass Vaccination | 1 | 2021 | 1101 | 0.03 | Why? |
| Spike Glycoprotein, Coronavirus | 1 | 2021 | 37182 | 0.03 | Why? |
| Public Opinion | 1 | 2020 | 1165 | 0.03 | Why? |
| Amino Acid Substitution | 1 | 2017 | 1706 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Telemedicine | 1 | 2020 | 25032 | 0.02 | Why? |
| Dexamethasone | 1 | 2020 | 2055 | 0.02 | Why? |
| Phylogeny | 2 | 2018 | 13341 | 0.02 | Why? |
| Sequence Analysis, DNA | 1 | 2017 | 2830 | 0.02 | Why? |
| Disease Reservoirs | 1 | 2017 | 1672 | 0.02 | Why? |
| Whole Genome Sequencing | 1 | 2018 | 3239 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Social Determinants of Health | 1 | 2017 | 1757 | 0.02 | Why? |
| Recurrence | 1 | 2015 | 3675 | 0.02 | Why? |
| Reproducibility of Results | 1 | 2020 | 11304 | 0.02 | Why? |
| Genetic Variation | 1 | 2017 | 3919 | 0.02 | Why? |
| Treatment Outcome | 2 | 2021 | 51732 | 0.01 | Why? |
| Health Behavior | 1 | 2020 | 4449 | 0.01 | Why? |
| Occupational Exposure | 1 | 2020 | 4742 | 0.01 | Why? |
| Anti-Inflammatory Agents | 1 | 2020 | 6153 | 0.01 | Why? |
| Triage | 1 | 2020 | 7151 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Time Factors | 1 | 2021 | 31397 | 0.01 | Why? |
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 9706 | 0.01 | Why? |
| Respiratory Tract Infections | 1 | 2017 | 6817 | 0.01 | Why? |
| Comorbidity | 1 | 2017 | 34796 | 0.01 | Why? |
| Practice Guidelines as Topic | 1 | 2015 | 15421 | 0.01 | Why? |
| Cross-Sectional Studies | 1 | 2018 | 53120 | 0.01 | Why? |
| Infection Control | 1 | 2018 | 23131 | 0.01 | Why? |
| RNA, Viral | 1 | 2017 | 32276 | 0.01 | Why? |
Hayward's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(195)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(160)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_